15 September 2014 - Takis' anti-ErbB3 mAbs tested in a novel organoid system at Vanderbilt University

Takis anti-ErbB3 antibodies were successfuly utilized in a novel system set up at Vanderbilt University. The article "Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer" appeared on Cancer Research on September Issue.

 For more info: http://www.ncbi.nlm.nih.gov/pubmed/25100563

Cancer Research september